By Traci Hacker

Beckley Psytech Limited, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, and Lophora ApS, a drug discovery company working in the central nervous system (CNS) arena, have entered into a research and development (R&D) collaboration. Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline and collaborate broadly on R&D. Founded in 2018 by University of Copenhagen’s Medicinal Chemistry Professor, Jesper Kristensen, Lophora is a highly regarded biotechnology company, based in Denmark, focused on the development of proprietary new chemical entities (NCEs) for treatment-resistant…